Exhibit 107
Calculation of Filing Fee Table
Form S-8
(Form Type)
INmune Bio Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
| Security Type | Security Class Title | Fee Calculation Rule | Amount Registered(1) | Proposed Maximum Offering Price Per Unit | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee | |||||||||||||||||
| Equity | Common Stock | Other(2) | 4,000,000 | $ | 9.005 | (3) | 36,020,000 | .0001102 | $ | 3,969.40 | ||||||||||||||
| Total Offering Amounts | $ | 3,969.40 | ||||||||||||||||||||||
| Total Fee Offsets | $ | 0.00 | ||||||||||||||||||||||
| Net Fee Due | $ | 3,969.40 | ||||||||||||||||||||||
| (1) | Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement on Form S-8 shall also cover any additional shares of common stock of INmune Bio Inc. that become issuable with respect to the securities identified in the above table, by reason of any stock dividend, stock split, recapitalization, reclassification, merger, split-up, reorganization, consolidation or other capital adjustment effected without receipt of consideration that increases the number of outstanding shares of common stock. |
| (2) | Calculated pursuant to Rules 457(c) and Rule 457(h) under the Securities Act of 1933, as amended. |
| (3) | Estimated solely for the purpose of calculating the registration fee pursuant to Rules 457(c) and 457(h) of the Securities Act, based on $9.005, the average of the high and low sales price of the common stock as reported on Nasdaq on June 16, 2023. |
